Thank you very much, Madam Chair.
Thank you very much for being here and presenting.
It's nice to see you again, Dr. Carleton.
I want to ask Dr. Law a couple of questions about vaccines and the surveillance around them. I think we've heard that almost all of the post-marketing surveillance activities lie within Health Canada, but I think your Public Health Agency is responsible for the marketing surveillance of preventative vaccines. What mechanisms are in place for the coordination and ongoing communication between the two departments?